Why I think Wesfarmers shares are a top buy right now

I'd put this ASX 200 stock in my shopping basket.

| More on:
A smiling man at a shop counter takes payment from a customer, with racks of plants in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Wesfarmers shares are 25% lower than the August 2021 high
  • I like the high-quality financial metrics of the business
  • The company has numerous growth routes, which can help long-term returns

The Wesfarmers Ltd (ASX: WES) share price looks like an appealing long-term buy in my opinion.

Why does the long-term part matter? I think all investing should be done with the long-term in mind, even if the investment gains play out sooner than expected.

I think good investing takes patience. Holding shares for a long time gives us a better chance for a good business to deliver good returns. It gives the business more time to deliver profit compound growth, which may help push the share price higher.

Plus, long-term investing means that investors can receive more dividends, which can be re-invested into more shares.

With the Wesfarmers share price down 25% from August 2021, I think it's a good time to invest for a few different reasons.

Attractive financials

With the company now priced at a materially lower level, we're getting the same business for a much better price.

Let's look at what the current price/earnings (P/E) ratio is. Commsec estimates currently suggest that Wesfarmers could generate $2.16 of earnings per share (EPS) in FY23. This puts the Wesfarmers share price at 23 times FY23's estimated earnings.

I think that's a very reasonable valuation considering the high-quality nature of the business.

The company achieved an overall return on equity (ROE) of 32.8% in the first half of FY23. That shows how much profit Wesfarmers generated from the shareholder money that is retained within the business.

Bunnings, the key profit generator of the business, saw a return on capital (ROC) of 70.7%.

These are the types of numbers that I'd want to see from my businesses. It also suggests that Wesfarmers can earn great returns on profit it re-invests within the business.

Growth platforms

I like that Wesfarmers is putting money into areas where it has a large growth opportunity with a long-term growth runway.

The hardware segment is huge, so Bunnings has plenty of growth avenues with commercial customers, tools and other areas. For example, it's expanding Tool Kit Depot into the east coast of Australia.

Wesfarmers' expansion into health and beauty with the acquisition of Priceline and Clear Skincare Clinics could turn into a very long-term play. The ASX share has identified spending trends and ageing demographics as two helpful tailwinds.

I think the Wesfarmers chemicals, energy and fertiliser (WesCEF) business is a very compelling segment. In the FY23 first half, WesCEF's earnings before tax (EBT) increased by 48.6% to $324 million. There is plenty of further growth potential here as it works on getting the Mt Holland lithium mine operational.

Having multiple growth avenues gives the business more compound growth potential, in my opinion.

Commitment to shareholder returns

Wesfarmers says that a key objective is to "provide a satisfactory return to shareholders".

I like this because I think it guides management's capital allocations, ensures they don't take any major risks with the business and look to provide growing cash returns in the form of dividends.

In FY23, Commsec numbers suggest that Wesfarmers is going to pay an annual dividend per share of $1.87. This could translate into a grossed-up dividend yield of 5.4%.

Over the past five years, the Wesfarmers share price has risen by 64%. Past performance is not a reliable indicator of future performance. But, I think it shows that the business is making steady long-term progress, and the market is recognising that.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »